Replies to post #748843 on NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

A good combination is probably DCVax-L with oncothermia therapy, but not everyone can afford the high cost. Oncothermia alone is a more affordable option, which would involve traveling to London for three 90-minute sessions a week at a cost of around £4,000 a month.

The EHY-2030 device is intended for the adjuvant treatment of glioblastoma in a combination regimen with chemotherapy and/or radiation therapy. The newly designed device includes the Smart Electrode system and the integrated Patient Management System (PMS) and a user-friendly touch screen display with full system control. The new RF generator with impulse mode increased peak power has been developed with a new intelligently controlled step motor tuning system for rapid impedance matching to achieve shorter tuning-time.

The EHY-2030 device is a CE-marked medical device, and is intended for professional use.

https://oncotherm.com/ehy-2030/
https://www.neurooncologycare.co.uk/treatments